UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section
13 OR 15(d) of The Securities Exchange Act Of 1934
|
Date of
Report (Date of earliest event reported)
|
August 24, 2009 |
|
THE PROCTER & GAMBLE
COMPANY
|
|
(Exact name
of registrant as specified in its
charter)
|
|
Ohio
|
1-434
|
31-0411980
|
||
|
(State or
other jurisdiction
of
incorporation)
|
(Commission
File Number)
|
(IRS
Employer
Identification
Number)
|
|
One Procter
& Gamble Plaza, Cincinnati, Ohio
|
45202
|
|
|
(Address of
principal executive offices)
|
Zip
Code
|
|
(513)
983-1100
|
45202
|
|
|
(Registrant's
telephone number, including area code)
|
Zip
Code
|
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR
240.14d-2(b))
|
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR
240.13e-4(c))
|
ITEM 7.01 REGULATION
FD DISCLOSURE
On August 24, 2009,
The Procter & Gamble Company (“Company”) and Warner Chilcott plc (“Warner
Chilcott”) issued a news release announcing that the companies have reached an
agreement for the sale of P&G’s global pharmaceuticals business to Warner
Chilcott.
The Company is
furnishing this 8-K pursuant to Item 7.01, "Regulation FD
Disclosure."
SIGNATURE
Pursuant to the requirements of the
Securities Exchange Act of 1934, the Registrant has duly caused this Report to
be signed on its behalf by the undersigned hereunto duly
authorized.
THE
PROCTER & GAMBLE COMPANY
BY: /S/
E.J.
WUNSCH
E.J. Wunsch
Assistant Secretary
August 24,
2009
EXHIBITS
|
99.1
|
News Release
by The Procter & Gamble Company and Warner Chilcott plc dated August
24, 2009.
|